title: A retrospective review of clinical experience with daptomycin for a variety of wound types in a burn and wound care facility.
abstract: OBJECTIVE
  Daptomycin is a novel antibiotic with activity against many Gram-positive organisms that has demonstrated efficacy in the management of skin and soft tissue infections (SSTIs). However, data regarding the use of daptomycin for the management of burn wound infections are lacking. We assessed the efficacy and safety of daptomycin in the treatment of complicated skin and soft tissue infections (cSSTIs), including burn wound infections.
  
  
  METHODS
  We performed a retrospective review of patients receiving daptomycin for burn wound infections and other cSSTIs in a referral burn and wound treatment center.
  
  
  RESULTS
  Our review revealed an overall success rate (microbiological cure + clinically improved) of 99.5%, with an overall success rate of 98.5% among burn patients, specifically. The overall success rate was 100% among patients in the three other diagnosis groups (cSSTIs, chronic wounds, and other infections). A success rate of 98% was noted among the subset of patients with wounds associated with bacteremia.
  
  
  CONCLUSIONS
  Our study suggests that daptomycin is a safe and effective agent for the management of burn wound infections, although further study is warranted to confirm these results.
authors.affiliation: Doctors Hospital of Augusta, Augusta, GA, USA.
authors.forename: Bruce C
authors.initials: BC
authors.lastname: Friedman
authors.forename: Luke
authors.initials: L
authors.lastname: Mendez-Vigo
authors.forename: Joan
authors.initials: J
authors.lastname: Wilson
authors.forename: Sara
authors.initials: S
authors.lastname: Yankelev
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy; D002053:Burn Units / Q000706:statistics & numerical data; D002056:Burns / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D017576:Daptomycin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005845:Georgia; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome; D014946:Wound Infection / Q000188:drug therapy* / Q000382:microbiology; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D017576:Daptomycin